

MCQOPTIONS
Saved Bookmarks
1. |
In Aug 2020, the Drug Controller General of India’s office has approved whose application for phase II and III clinical trials of the University of Oxford’s COVID-19 vaccine candidate Covishield? |
A. | Panacea Biotec |
B. | Shantha Biotechnics |
C. | Biocon |
D. | Serum Institute of India |
E. | Sun Pharma |
Answer» E. Sun Pharma | |